1988
DOI: 10.1182/blood.v72.6.2001.2001
|View full text |Cite
|
Sign up to set email alerts
|

Down regulation of myelopoiesis by mediators inhibiting the production of macrophage-derived granulomonopoietic enhancing activity (GM-EA)

Abstract: Monocyte-derived lipid-containing macrophages (MDLMs) constitutively synthesize a granulomonopoietic enhancing activity (GM-EA) that potentiates the function of granulocyte-macrophage colony-stimulating activity (GM-CSA). In the study reported, we show that GM-EA is distinct from interleukin-1 (IL-1) in biochemical and functional properties and that its production is negatively regulated by several mediators. Thus, MDLM cultures pretreated with interferon-gamma (IFN- gamma, 3 to 900 U/mL), prostaglandin E2 (PG… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

1990
1990
2001
2001

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 28 publications
1
1
0
Order By: Relevance
“…Resting T cells do not release TNF-dIFN-y and are unable to inhibit GM-EF production. The downregulatory role of IFN-y in GM-EF production has been reported previously [8]. Our present studies further confirm this finding and suggest that the most intense GM-EF suppression induced by activated T cells may be the result of a cooperative effect of TNF-a and IFN-y.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Resting T cells do not release TNF-dIFN-y and are unable to inhibit GM-EF production. The downregulatory role of IFN-y in GM-EF production has been reported previously [8]. Our present studies further confirm this finding and suggest that the most intense GM-EF suppression induced by activated T cells may be the result of a cooperative effect of TNF-a and IFN-y.…”
Section: Discussionsupporting
confidence: 92%
“…GM-EF is produced constitutively by fully mature macrophages [5]. It acts specifically on myeloid lineage [6,8,9], targeting on an earlier subpopulation of myeloid progenitor cells, pre-CFU-GM [9], but has no effect on either erythroid (BFU-E) or pluripotent (CFU-GEMM) progenitor cells [6]. The productiodrelease of GM-EF is promoted and suppressed by different regulators involved in myelopoiesis [7,81.…”
Section: Introductionmentioning
confidence: 99%